Xilio Therapeutics, Inc.
US ˙ NasdaqGS ˙ US98422T1007

Introduction

This page provides a comprehensive analysis of the known insider trading history of Timothy P Clackson. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Timothy P Clackson has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ELEV / Elevation Oncology, Inc. Director 0
US: / THESEUS PHARMACEUTICALS INC President and CEO, Director 351,030
US:FMTX / Forma Therapeutics Holdings Inc Director 0
US:XLO / Xilio Therapeutics, Inc. 10% Owner 20,068
US:849CVR014 / CVR F STAR Director 50,486
US:ARIA / ARIAD Pharmaceuticals, Inc. President, R&D, CSO 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Timothy P Clackson. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases XLO / Xilio Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in XLO / Xilio Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XLO / Xilio Therapeutics, Inc. Insider Trades
Insider Sales XLO / Xilio Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in XLO / Xilio Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XLO / Xilio Therapeutics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Timothy P Clackson as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-07-24 2025-07-23 4 ELEV Elevation Oncology, Inc.
Common Stock
U - Other -47,330 0 -100.00 0.36 -17,039
2023-09-05 2023-09-01 4 ELEV Elevation Oncology, Inc.
Common Stock
G - Gift -15,777 0 -100.00
2022-11-14 2022-11-11 4 THRX Theseus Pharmaceuticals, Inc.
Common Stock
P - Purchase 2,500 351,030 0.72 6.80 16,995 2,386,302
2022-10-14 2022-10-14 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
U - Other -7,250 0 -100.00
2022-10-14 2022-10-14 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
U - Other -23,590 0 -100.00
2022-06-22 2022-05-31 4 ELEV Elevation Oncology, Inc.
Common Stock
G - Gift -31,553 15,777 -66.67
2022-06-09 2022-06-08 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
A - Award 4,500 30,840 17.08
2022-02-23 2022-02-18 4 THRX Theseus Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 450,000 450,000
2021-12-22 2021-12-21 4 THRX Theseus Pharmaceuticals, Inc.
Common Stock
P - Purchase 2,600 348,530 0.75 9.76 25,381 3,402,385
2021-10-21 3 XLO Xilio Therapeutics, Inc.
Common Stock
20,068
2021-10-21 3 XLO Xilio Therapeutics, Inc.
Common Stock
70,888
2021-10-06 3 THRX Theseus Pharmaceuticals, Inc.
Common Stock
345,930
2021-06-24 3 ELEV Elevation Oncology, Inc.
Common Stock
47,330
2021-06-21 2021-06-17 4 FMTX Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 8,375 8,375
2021-06-21 2021-06-17 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
A - Award 2,750 26,340 11.66
2020-10-01 2020-09-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 9,422 50,486 22.94
2020-07-01 2020-06-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 8,588 41,064 26.44
2020-06-25 2020-06-24 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 7,500 7,500
2020-06-24 2020-06-23 4 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
S - Sale -35,067 0 -100.00
2020-06-24 2020-06-23 4 FMTX Forma Therapeutics Holdings, Inc.,
Common Stock
P - Purchase 23,590 23,590
2020-06-22 2020-06-18 4 FMTX Forma Therapeutics Holdings, Inc.,
Stock Option (Right to Buy)
A - Award 17,533 0 -100.00
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43,144
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43,144
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43,144
2020-04-01 2020-03-31 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 13,575 32,476 71.82
2020-01-02 2019-12-31 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 7,991 18,901 73.24
2019-10-01 2019-09-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 3,670 10,910 50.69
2019-07-11 2019-07-10 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 7,500 7,500
2019-07-01 2019-06-28 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 3,421 7,240 89.58
2019-04-02 2019-03-29 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 1,204 3,819 46.04
2019-01-03 2019-01-02 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 1,083 2,615 70.69
2018-10-02 2018-10-01 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 788 1,532 105.91
2018-07-03 2018-07-02 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 744 744
2018-03-05 2018-03-01 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 11,000 11,000
2018-03-05 3 SBPH Spring Bank Pharmaceuticals, Inc.
No securities are beneficially owned
0
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -14,550 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -72,980 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -87,125 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -65,000 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -82,000 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -577 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -219,867 0 -100.00
2017-02-07 2017-02-06 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 14,550 14,550
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29,333 0 -100.00
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -9,610 219,867 -4.19 23.82 -228,886 5,236,682
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29,333 229,477 14.66
2016-10-25 2016-10-24 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -19,638 197,884 -9.03 9.56 -187,739 1,891,771
2016-09-28 2016-09-28 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8,750 217,522 -3.87 13.98 -122,311 3,040,610
2016-09-28 2016-09-26 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -17,500 0 -100.00
2016-09-28 2016-09-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 17,500 226,272 8.38
2016-09-23 2016-09-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -20,000 208,772 -8.74 13.43 -268,536 2,803,140
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -59,369 0 -100.00
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -59,369 228,772 -20.60 11.73 -696,398 2,683,496
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 59,369 288,141 25.95 7.82 464,266 2,253,263
2016-08-23 2016-08-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -19,436 228,772 -7.83 10.47 -203,538 2,395,746
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -25,000 0 -100.00
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -25,000 248,208 -9.15 10.50 -262,500 2,606,184
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 25,000 273,208 10.07 7.69 192,250 2,100,970
2016-07-25 2016-07-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -18,286 248,208 -6.86 8.11 -148,230 2,012,024
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -30,000 0 -100.00 3.25 -97,500
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -31,422 0 -100.00 4.49 -141,085
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -30,000 266,494 -10.12 7.48 -224,481 1,994,095
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 30,000 296,494 11.26 3.25 97,500 963,606
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -31,422 266,494 -10.55 7.48 -235,153 1,994,361
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 31,422 297,916 11.79 4.49 141,085 1,337,643
2016-06-23 2016-06-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23,999 264,742 -8.31 7.28 -174,638 1,926,501
2016-05-25 2016-05-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -17,762 288,741 -5.80 8.08 -143,430 2,331,612
2016-05-02 2016-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -11,700 306,503 -3.68 7.13 -83,478 2,186,868
2016-05-02 2016-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -23,400 0 -100.00
2016-05-02 2016-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 23,400 318,203 7.94
2016-04-25 2016-04-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -21,409 294,803 -6.77 7.37 -157,864 2,173,789
2016-03-23 2016-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23,834 316,212 -7.01 6.58 -156,871 2,081,244
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10,833 0 -100.00
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5,417 340,046 -1.57 6.47 -35,039 2,199,520
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,833 345,463 3.24
2016-03-09 2016-03-07 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 26,180 26,180
2016-03-09 2016-03-07 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 87,125 87,125
2016-03-03 2016-03-03 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9,625 334,630 -2.80 6.12 -58,867 2,046,631
2016-03-03 2016-03-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -25,047 344,255 -6.78 6.00 -150,282 2,065,530
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 38,500 38,500
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -19,250 19,250 -50.00
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19,250 369,302 5.50
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29,333 29,333 -50.00
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14,667 350,052 -4.02 4.81 -70,517 1,683,015
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29,333 364,719 8.75
2015-09-28 2015-09-28 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8,750 334,086 -2.55 6.46 -56,560 2,159,532
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 35,000 35,000
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -17,500 17,500 -50.00
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 17,500 342,836 5.38
2015-07-16 2015-07-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7,000 325,336 -2.11 8.54 -59,797 2,779,150
2015-07-16 2015-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -14,000 0 -100.00
2015-07-16 2015-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 14,000 332,336 4.40
2015-04-30 2015-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 70,200 70,200
2015-04-27 2015-04-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -123,766 316,548 -28.11 9.50 -1,175,777 3,007,206
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,333 0 -100.00
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6,667 440,314 -1.49 8.55 -57,016 3,765,565
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,333 446,981 3.07
2015-03-23 2015-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5,417 433,648 -1.23 8.84 -47,910 3,835,313
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -20,657 0 -100.00
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10,833 10,833 -50.00
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -20,657 440,314 -4.48 9.00 -185,913 3,962,826
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 20,657 460,971 4.69 7.56 156,167 3,484,941
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,833 439,065 2.53
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -24,036 31,422 -43.34
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -24,999 0 -100.00
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -24,036 428,232 -5.31 8.00 -192,288 3,425,856
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 24,036 452,268 5.61 4.49 107,922 2,030,683
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -24,999 428,232 -5.52 8.00 -199,992 3,425,856
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 24,999 453,231 5.84 2.62 65,497 1,187,465
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29,334 58,666 -33.33
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14,667 428,232 -3.31 6.33 -92,820 2,710,066
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29,334 442,899 7.09
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -14,000 14,000 -50.00
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -4,564 413,565 -1.09 5.57 -25,421 2,303,557
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 14,000 418,129 3.46
2014-04-03 2014-04-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6,500 403,028 -1.59 8.21 -53,337 3,307,127
2014-04-03 2014-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,000 0 -100.00
2014-04-03 2014-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,000 409,528 3.28
2014-03-21 2014-03-21 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6,667 394,377 -1.66 7.89 -52,583 3,110,451
2014-03-21 2014-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,333 13,333 -50.00
2014-03-21 2014-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,333 401,044 3.44
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10,834 21,666 -33.34
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -3,442 387,711 -0.88 8.19 -28,190 3,175,353
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,834 391,153 2.85
2014-02-04 2014-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 88,000 88,000
2013-12-20 2013-12-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9,750 380,319 -2.50 5.14 -50,115 1,954,840
2013-12-20 2013-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19,500 390,069 5.26
2013-09-10 2013-09-06 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8,449 370,451 -2.23 22.00 -185,878 8,149,922
2013-07-18 2013-07-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14,000 378,900 -3.56 19.79 -277,045 7,498,014
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -28,000 28,000 -50.00
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 56,000 56,000
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 28,000 392,900 7.67
2013-04-03 2013-04-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -6,500 363,705 -1.76 18.04 -117,245 6,560,402
2013-04-03 2013-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,000 0 -100.00
2013-04-03 2013-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,000 370,205 3.64
2013-03-26 2013-03-25 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -19,167 357,205 -5.09 18.87 -361,766 6,742,030
2013-03-26 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -38,333 0 -100.00
2013-03-26 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 38,333 376,372 11.34
2013-03-22 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -6,667 338,039 -1.93 19.46 -129,718 6,577,123
2013-03-22 2013-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,334 0 -100.00
2013-03-22 2013-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,334 344,706 4.02
2013-03-20 2013-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 65,000 65,000
2013-03-20 2013-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 32,500 32,500
2013-03-05 2013-03-04 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9,838 331,372 -2.88 21.00 -206,598 6,958,812
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -8,631 17,262 -33.33
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -44,542 0 -100.00
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -4,766 0 -100.00
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 8,631 341,210 2.60 7.82 67,494 2,668,262
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 44,542 332,579 15.46 4.49 199,994 1,493,280
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 4,766 288,037 1.68 5.23 24,926 1,506,434
2012-12-21 2012-12-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -27,000 4,766 -85.00
2012-12-21 2012-12-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 27,000 282,940 10.55 5.23 141,210 1,479,776
2012-12-20 2012-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -8,142 255,940 -3.08 20.18 -164,306 5,164,869
2012-12-20 2012-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19,500 264,082 7.97
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -1 24,999 0.00
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -10,000 30,000 -25.00
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 1 244,170 0.00 2.62 3 639,725
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 244,169 4.27 3.25 32,500 793,549
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -36,843 0 -100.00
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -36,843 234,169 -13.59 20.00 -736,860 4,683,380
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 36,843 271,012 15.73 7.56 278,533 2,048,851
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -23,234 31,766 -42.24
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23,234 234,169 -9.03 19.00 -441,446 4,449,211
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 23,234 257,403 9.92 5.23 121,514 1,346,218
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -20,000 0 -100.00
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -20,000 233,778 -7.88 17.00 -340,000 3,974,226
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 20,000 253,778 8.56 7.44 148,800 1,888,108
2012-04-17 2012-04-17 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7,111 233,778 -2.95 15.00 -106,665 3,506,670
2012-04-17 2012-04-13 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -31,600 240,889 -11.60 14.83 -468,628 3,572,384
2012-04-03 2012-04-03 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5,200 272,489 -1.87 16.18 -84,134 4,408,763
2012-04-03 2012-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,000 26,000 -33.33
2012-04-03 2012-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,000 277,689 4.91
2012-04-03 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -26,061 264,689 -8.96 16.34 -425,876 4,325,415
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -7,500 0 -100.00
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7,500 290,750 -2.51 16.00 -120,000 4,652,000
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 7,500 298,250 2.58 6.39 47,925 1,905,818
2012-03-26 2012-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -15,333 290,750 -5.01 15.41 -236,211 4,479,120
2012-03-26 2012-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -38,333 38,333 -50.00
2012-03-26 2012-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 38,333 306,083 14.32
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 40,000 40,000
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 82,000 82,000
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -36,400 267,750 -11.97 15.02 -546,622 4,020,829
2012-03-21 2012-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise 91,000 0 -100.00
2012-03-21 2012-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise -91,000 304,150 -23.03
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -8,449 0 -100.00
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -6,615 0 -100.00
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 8,449 213,150 4.13 4.19 35,401 893,098
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 6,615 204,701 3.34 4.05 26,791 829,039
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -16,500 16,500 -50.00
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -41,551 8,449 -83.10
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -18,385 6,615 -73.54
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -76,436 119,882 -38.93 15.12 -1,155,781 1,812,724
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 16,500 196,318 9.18 3.90 64,350 765,640
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 41,551 179,818 30.05 4.19 174,099 753,437
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 18,385 138,267 15.34 4.05 74,459 559,981
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)